Comparison of a non-antibiotic treatment with an antibiotic treatment of chronic mastitis

  • V. Krömker
  • N. Wente
  • Y. Zhang
  • J. Bolte
  • R. Renner
  • A. Schmenger
  • I. Titze
  • J. Wallis
  • P. Mayer
  • D. Klocke University of applied sciences and arts - Faculty II, Department of Bioprocess Engineering – Microbiology
Keywords: recurrent mastitis, clinical cure, bacteriological cure, non-severe clinical mastitis, alternative mastitis therapy

Abstract

A non-blinded, positively controlled trial was conducted to evaluate the efficacy of an alternative, non-antibiotic therapy with Pyrogenium® to reduce ineffective antibiotic usage in the treatment of non-severe clinical mastitis (CM) in cows with longer lasting udder diseases. The solely treatment with Pyrogenium® (6 times, at a 12 hourly interval and then 4 times in a 24-hour interval) were compared with the reference treatment of solely local antibiotic therapy. The matched field study was conducted on five free-stall dairy farms located in Northern Germany. Cases of mild-to-moderate CM in cows with longer lasting high somatic cell counts in preceding dairy herd improvement test days and with previous CM cases in current lactation (chronic mastitis) were randomly allocated to one of the two treatment groups. A foremilk sample of the affected quarter was taken before treatment and again approximately 7 days, 14 days and 21 days after the end of therapy for cyto-bacteriological examination. Primary outcome was clinical cure (CC). Bacteriological cure (BC), quarter somatic cell count cure (CYC) and CM recurrence within 60 days after the end of treatment were chosen as secondary outcomes although low probabilities of bacteriological cure and quarter somatic cell count cure for selected cows were expected. The study resulted in the following findings: the pathogens mostly cultured from pretreatment samples were Staphylococcus aureus, followed by Streptococcus uberis. There were no significant differences between the test treatment (EG) in comparison with the reference treatment (CG) regarding all outcome variables (e.g. CC: EG 60.0%, CG 54.7%). Having regard to the selection criteria of cows in this study, the findings indicated that sole treatment with Pyrogenium® in non-severe CM cases may constitute an alternative therapy to reduce antibiotics.

References

Halasa T, Nielen M, De Roos AP, Van Hoorne R, De Jong G, Lam TJ, Van Werven T, Hogeveen H. Production loss due to new subclinical mastitis in Dutch dairy cows estimated with a test-day model. J Dairy Sci 2009; 92: 599–606. 10.3168/jds.2008-1564
Picker JC. Aspects of recurrent mastitis. Master thesis 2012, University Göttingen.
Zoche-Golob V, Spilke J. Herd-specific estimation of milk yield reduction due to recurrent clinical mastitis. Berl Münch Tierarztl Wochenschr 2013; 126 (7–8): 269–276.
Wolfová M, Stípková M, Wolf J. Incidence and economics of clinical mastitis in five Holstein herds in the Czech Republic. Prev Vet Med 2006; 77: 48-64.
Bar D, Grohn YT, Bennett G, Gonzalez RN, Hertl JA, Schulte HF, Tauer LW, Welcome FL, Schukken YH. Effect of repeated episodes of generic clinical mastitis on milk yield in dairy cows. J Dairy Sci 2007; 90: 4643-4653.
Linder M, Paduch J-H, Grieger AS, Mansion-de Vries E, Knorr N, Zinke C, Teich K, Krömker V. Heilungsraten chronischer subklinischer Staphylococcus aureus-Mastitiden nach antibiotischer Therapie bei laktierenden Milchkühen. Berl Münch Tierarztl Wochenschr 2013; 126 (7–8), 291–296.
Barkema HW, De Vliegher S, Piepers S, Zadoks RN. Herd level approach to high bulk milk somatic cell count problems in dairy cattle. Vet Q 2013; 33(2): 82–93.
Krömker V, Friedrich J. Empfehlungen zum diagnostischen Aufwand im Rahmen der Mastitisbekämpfung auf Bestandsebene. Prakt Tierarzt 2011; 92: 516–524.
GVA [German Veterinary Association]. Guidelines for aseptic milk sampling and guidelines to isolate and identify mastitis pathogens, 2009; 2nd ed. Germany: Gießen.
NMC (National Mastitis Council). Laboratory handbook on bovine mastitis, 1999, Revised ed. Madison WI, USA: NMC.
Watts JL, Salmon SA, Yancey RJJ. Use of modified Rambach agar to differentiate Streptococcus uberis from other mastitis streptococci. J Dairy Sci 1993; 76: 1740–1743.
Schukken YH, Zurakowski MJ, Rauch BJ, Gross B, Tikofsky LL, Welcome FL. Noninferiority trial comparing a first-generation cephalosporin with a third-generation cephalosporin in the treatment of nonsevere clinical mastitis in dairy cows. J Dairy Sci 2013; 96: 6763–6774.
Swinkels JM, Krömker V, Lam TJGM. Efficacy of standard vs. extended intramammary cefquinome treatment of clinical mastitis in cows with persistent high somatic cell counts. J Dairy Res 2014; 81:424–433.
Ziesch M, Wente N, Zhang Y, Zaremba W, Engl S, Krömker V. Noninferiority trial investigating the efficacy of a nonantibiotic intramammary therapy in the treatment of mild-to-moderate clinical mastitis in dairy cows with longer lasting udder diseases. J Vet Pharmacol Ther 2018;. 41(1):11-21. doi: 10.1111/jvp.12415.
Mansion-de Vries EM, Lücking J, Wente N. Zinke C, Hoedemaker M, Krömker V. Comparison of an evidence-based and a conventional mastitis therapy concept with regard to cure rates and antibiotic usage. Milk Sci Int 2016; 69: 27-32
Ruegg, PL. The application of evidence based veterinary medicine to mastitis therapy. Santiago, Chile: World Buiatrics Congress, 2010.
Published
2019-07-08